Stock HRGN HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Harvard Apparatus Regenerative Technology Inc.

Equities

HRGN

US09074M2026

Market Closed - OTC Markets
Other stock markets
 19:02:25 10/05/2024 BST 		5-day change 1st Jan Change
2.32 USD +3.11% Intraday chart for Harvard Apparatus Regenerative Technology Inc. -5.69% -53.51%
04-15 Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding CI
03-28 Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Harvard Apparatus Regenerative Technology : Q1 - 2024 HBIO Quarterly Earnings Presentation
PU
Harvard Apparatus Regenerative Technology : March 19, 2024 - Investor Presentation
PU
Harvard Apparatus Regenerative Technology : Q4 - 2023 HBIO Quarterly Earnings Presentation
PU
Harvard Apparatus Regenerative Technology : Northland Capital Markets Institutional Investor Conference 2023
PU
Harvard Apparatus Regenerative Technology : Q2 - 2023 HBIO Quarterly Earnings Presentation
PU
Biostage Activated Mayo Clinic as the First Site for Clinical Trial in Severe Esophageal Disease
AQ
Purcell & Lefkowitz LLP Is Investigating Biostage, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
PR
Biostage to Host Investor Call
PR
Biostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal Disease
AQ
BIOSTAGE, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Biostage Appoints Ron Packard to Board of Directors
AQ
BIOSTAGE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Biostage Announces $6 Million Financing to Advance Clinical Trial
AQ
BIOSTAGE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
BIOSTAGE, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Biostage Announces Chairman and CEO Transition
PR
BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers (form 8-K)
AQ
BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Biostage Amends CEO Employment Agreement
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HRGN Stock
  4. News Harvard Apparatus Regenerative Technology Inc.
  5. Press Releases